Dunn Edmund bought GLUE
February 27, 2026 · Form 4 insider transaction
Dunn Edmund bought 25,164 shares of Monte Rosa Therapeutics, Inc. at $13.41 per share, a transaction worth $337.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,164
Price
$13.41
Total value
$337.4K
InsiderDunn Edmund
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 27, 2026
Filing dateMarch 2, 2026
Shares owned after47,857
OwnershipDirect
10b5-1 planNo
AmendedNo